These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 9676593)

  • 1. Comparison of production of Staphylococcus intermedius exotoxin among clinically normal dogs, atopic dogs with recurrent pyoderma, and dogs with a single episode of pyoderma.
    Burkett G; Frank LA
    J Am Vet Med Assoc; 1998 Jul; 213(2):232-4. PubMed ID: 9676593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence of Staphylococcus intermedius to corneocytes of healthy and atopic dogs: effect of pyoderma, pruritus score, treatment and gender.
    Simou C; Thoday KL; Forsythe PJ; Hill PB
    Vet Dermatol; 2005 Dec; 16(6):385-91. PubMed ID: 16359305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of Staphylococcus pseudintermedius isolates from atopic and healthy dogs.
    Fazakerley J; Williams N; Carter S; McEwan N; Nuttall T
    Vet Dermatol; 2010 Dec; 21(6):578-85. PubMed ID: 20456718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcal colonization of mucosal and lesional skin sites in atopic and healthy dogs.
    Fazakerley J; Nuttall T; Sales D; Schmidt V; Carter SD; Hart CA; McEwan NA
    Vet Dermatol; 2009 Jun; 20(3):179-84. PubMed ID: 19392768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of adherence by four strains of Staphylococcus intermedius and Staphylococcus hominis to canine corneocytes collected from normal dogs and dogs suffering from atopic dermatitis.
    McEwan NA; Kalna G; Mellor D
    Res Vet Sci; 2005 Jun; 78(3):193-8. PubMed ID: 15766937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma.
    Hartmann FA; White DG; West SE; Walker RD; Deboer DJ
    Vet Microbiol; 2005 Jun; 108(1-2):119-31. PubMed ID: 15917140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence by Staphylococcus intermedius to canine keratinocytes in atopic dermatitis.
    Mcewan NA
    Res Vet Sci; 2000 Jun; 68(3):279-83. PubMed ID: 10877976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.
    Ganière JP; Médaille C; Etoré F
    Res Vet Sci; 2004 Aug; 77(1):67-71. PubMed ID: 15120955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protein A from Staphylococcus intermedius isolated from canine skin.
    Fehrer SL; Boyle MD; Halliwell RE
    Am J Vet Res; 1988 May; 49(5):697-701. PubMed ID: 3395013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma.
    Ganiere JP; Medaille C; Mangion C
    J Vet Med B Infect Dis Vet Public Health; 2005 Feb; 52(1):25-31. PubMed ID: 15702997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence by Staphylococcus intermedius to canine corneocytes: a preliminary study comparing noninflamed and inflamed atopic canine skin.
    McEwan NA; Mellor D; Kalna G
    Vet Dermatol; 2006 Apr; 17(2):151-4. PubMed ID: 16515659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Masked, controlled study to investigate the efficacy of a Staphylococcus intermedius autogenous bacterin for the control of canine idiopathic recurrent superficial pyoderma.
    Curtis CF; Lamport AI; Lloyd DH
    Vet Dermatol; 2006 Jun; 17(3):163-8. PubMed ID: 16674730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of aerobic bacteriologic culture of epidermal collarette specimens in dogs with superficial pyoderma.
    White SD; Brown AE; Chapman PL; Jang SS; Ihrke PJ
    J Am Vet Med Assoc; 2005 Mar; 226(6):904-8. PubMed ID: 15786991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility profiles of Staphylococcus intermedius isolates from clinical cases of canine pyoderma in South Africa.
    Blunt CA; van Vuuren M; Picard J
    J S Afr Vet Assoc; 2013 May; 84(1):E1-6. PubMed ID: 23718758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of Staphylococcus intermedius isolates from canine pyoderma and from healthy carriers by SDS-PAGE of exoproteins, immunoblotting and restriction endonuclease digest analysis.
    Allaker RP; Garrett N; Kent L; Noble WC; Lloyd DH
    J Med Microbiol; 1993 Dec; 39(6):429-33. PubMed ID: 7902443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of Staphylococcus schleiferi from dogs with pyoderma.
    Frank LA; Kania SA; Hnilica KA; Wilkes RP; Bemis DA
    J Am Vet Med Assoc; 2003 Feb; 222(4):451-4. PubMed ID: 12597417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners.
    Guardabassi L; Loeber ME; Jacobson A
    Vet Microbiol; 2004 Jan; 98(1):23-7. PubMed ID: 14738778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Staphylococcus intermedius and Staphylococcus schleiferi isolated from dogs.
    Vanni M; Tognetti R; Pretti C; Crema F; Soldani G; Meucci V; Intorre L
    Res Vet Sci; 2009 Oct; 87(2):192-5. PubMed ID: 19268332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing a canine superficial pyoderma model.
    Bäumer W; Bizikova P; Jacob M; Linder KE
    J Appl Microbiol; 2017 Feb; 122(2):331-337. PubMed ID: 27891724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of superantigen-producing Staphylococcus intermedius isolates from canine pyoderma and proliferation-inducing potential of superantigens in dogs.
    Hendricks A; Schuberth HJ; Schueler K; Lloyd DH
    Res Vet Sci; 2002 Dec; 73(3):273-7. PubMed ID: 12443685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.